ReNetX gets Fast Track for spinal cord treatment
ReNetX Bio reports that the FDA has granted the company Fast Track Designation for ReNetX Bio’s clinical therapy (AXER-204) for the potential treatment of Chronic Spinal...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
ReNetX Bio reports that the FDA has granted the company Fast Track Designation for ReNetX Bio’s clinical therapy (AXER-204) for the potential treatment of Chronic Spinal...
Gary Mathias, Co-Founder and CEO of Thetis Pharmaceuticals, recently shared the following message. Happy New Year from the Thetis team! I am glad to report...
ABCT, the Accelerator for Biosciences in Connecticut, has announced the second cohort of emerging biosciences ventures invited to participate in its annual program. The 2020 ABCT cohort...
From Athletic Brewing to Zorus over the span of 2019, Connecticut startups had a boom year in landing outside funding as they conceptualized and delivered...
CTNext is looking for startup companies that are poised for growth, but need access to some specialized, quality expertise to accelerate to the next level....
In the last decade, scientists discovered that blocking a key regulator of the immune system helped unleash the body’s natural defenses against several forms of...
The Jackson Laboratory (JAX) has received $2.5 million from The Mark Foundation for Cancer Research to study in mice the influence of host genetics on...
BioXcel Therapeutics has announced announced the initiation of its SERENITY (Sub-Lingual DExmedetomidine in Agitation Associated With SchizophRENIa and Bipolar Disorder STudY) program, two Phase 3 studies of...
Melinta Therapeutics has entered into a restructuring support agreement with the lenders pursuant to a pre-negotiated chapter 11 plan of reorganization. “We are confident that...
Alexion Pharmaceuticals and Dicerna™ Pharmaceuticals have announced that Alexion has exercised its option for exclusive rights to two additional targets within the complement pathway for...